The Lancet
Systematic review
Dec 2017
For professionals
A review of population studies from around the world. In Western countries the number of new cases is levelling off but more than 0.3% of people now live with IBD. In newly industrialised countries in Asia, Africa and South America, new cases are rising quickly as lifestyles become more Western.
Topics
About Crohn's disease
Research
Jargon explained
systematic review
incidence
prevalence
population-based study
NHS
Web page
Dec 2022
For patients
The NHS explains what a clinical trial is and how to find one. It suggests asking your doctor or a patient organisation, and points to the Be Part of Research website, where you can search UK studies and contact researchers.
Topics
Research
Jargon explained
clinical trial
randomised
The Lancet
Study
Dec 2017
Patients and professionals
CALM compared deciding treatment on symptoms alone with 'tight control', where treatment was stepped up if blood or poo tests (CRP and faecal calprotectin) showed inflammation even when people felt fine. After 48 weeks, 46% in the tight control group had a healed bowel lining compared with 30% in the symptom-only group. It is a cornerstone of the 'treat to target' approach.
Topics
Monitoring
Biologics and newer medicines
Research
Jargon explained
tight control
faecal calprotectin
CRP
mucosal healing
treat to target
Crohn's & Colitis UK
Web page
Jul 2026
For patients
Explains how new IBD medicines move from lab testing through clinical trials to licensing, and describes medicines currently in late-stage testing.
Topics
Research
Medicines
Jargon explained
clinical trial
licensing
phase 3
US National Library of Medicine
Tool
Patients and professionals
The largest worldwide database of clinical studies, run by the US government. It includes many trials running at UK hospitals, often drug-company trials of new Crohn's medicines. Each record lists the study's aim, who can join and where.
Topics
Research
Jargon explained
clinical trial
eligibility criteria
trial registry
NCT number
The Lancet
Study
May 2022
Patients and professionals
Two trials testing risankizumab (Skyrizi) drips to bring active Crohn's under control, including in people for whom other biologics had failed. Risankizumab led to more remissions, and more improvement seen on camera tests of the bowel, at 12 weeks than placebo, and was generally well tolerated.
Topics
Biologics and newer medicines
Jargon explained
induction
phase 3 trial
endoscopic response
BMC Gastroenterology
Data
Mar 2021
For professionals
Another big UK GP-records study, covering 2006 to 2016. It found IBD rose by about a third over that time to roughly 1.4% of patients, higher than earlier estimates. The authors point out that the answer depends heavily on how a 'case' is defined, which may explain why older figures were lower.
Topics
About Crohn's disease
Research
Jargon explained
retrospective cohort study
prevalence
incidence
BMJ Open via PubMed Central
Study
Jul 2020
For professionals
A study of more than 11 million people's GP records from 2000 to 2018 tracking new IBD diagnoses in the UK. It found new cases in adults were stable or falling, but UK rates are among the highest reported anywhere, with a large rise in new diagnoses among teenagers.
Topics
About Crohn's disease
Research
Jargon explained
incidence
prevalence
cohort study
primary care
NIHR
Tool
For patients
The NHS research service's search tool for finding health studies to take part in across the UK. Searching for Crohn's disease lists studies currently recruiting, with who can join and where. A good first stop if you want to volunteer for a trial.
Topics
Research
Jargon explained
clinical trial
recruiting
Cochrane
Systematic review
Feb 2019
Patients and professionals
Reviewed trials of special diets (such as low-sugar, low-red-meat or exclusion diets) for Crohn's and colitis. The effects were uncertain and no firm conclusions could be drawn. The authors say experts need to agree what the diets should contain and more trials are needed.
Topics
Diet and nutrition
Jargon explained
dietary intervention
randomised controlled trial
Cochrane
Systematic review
Feb 2019
Patients and professionals
A Cochrane review of 18 trials that tested cutting down or cutting out foods thought to provoke IBD symptoms. The authors found the evidence too weak to say whether any of these diets help bring on or keep remission, and called for better trials. This summary dates from 2019.
Topics
Diet and nutrition
Research
Jargon explained
remission
exclusion diet
randomised controlled trial
Cochrane
Systematic review
Nov 2021
Patients and professionals
Tummy pain often continues in Crohn's even when inflammation is under control. This review looked for treatments aimed at the pain itself but found so few, small studies that no conclusions could be drawn.
Topics
Pain
Research
Jargon explained
abdominal pain
sham
remission
stricture
adhesions
low fodmap diet